MAP3K7CL Antikörper (AA 215-241) (FITC)
Kurzübersicht für MAP3K7CL Antikörper (AA 215-241) (FITC) (ABIN1911779)
Target
Alle MAP3K7CL Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 215-241
-
Spezifität
- This TAK1L antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 215-241 amino acids from the C-terminal region of human TAK1L.
-
Aufreinigung
- Affinity purified
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: ELISA, WB
Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, no preservatives added
-
Konservierungsmittel
- Without preservative
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Short term: store at 4°C. Long term: aliquot and store -20°C for up to 6 months. Avoid freeze-thaw cycles. Protect from light.
-
Haltbarkeit
- 6 months
-
-
- MAP3K7CL (MAP3K7 C-Terminal Like (MAP3K7CL))
-
Andere Bezeichnung
- MAP3K7CL / TAK1L
-
Hintergrund
-
Name/Gene ID: MAP3K7CL
Synonyms: MAP3K7CL, HC21ORF7, MAP3K7 c-terminal like, TAK1-like protein, TAK1-like protein 2, TAKL, TAKL-2, TGF-beta activated kinase, TAKL-4, TAK1L, C21orf7, TAK1-like protein 1, TAK1-like protein 4, TAKL-1 -
Gen-ID
- 56911
Target
-